ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

In Brief: NCI, OMB Heading For November Confrontation Over Hawaii, Papanicolaou Construction Funds

October 17, 1975

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004